Cardiac Amyloidosis

Dr. Rodney H. Falk is the Director of the Cardiac Amyloidosis Program and a cardiovascular medicine specialist at Brigham and Women's Hospital (BWH). He is also an…

Stephen Heitner is a Senior Medical Director at Cytokinetics. Previously he worked as a Cardiologist at Oregon Health & Science University (OHSU). He received…

Martha Grogan is a Cardiologist-Internist at Mayo Clinicexternal link, opens in a new tab, Rochester, Minnesota. She completed her graduation with distinction in…

Treatment with the investigational drug tafamidis was associated with a reduction in all-cause mortality and cardiovascular hospitalizations in patients with…

Amyloidosis is a disorder in which certain proteins abnormally change their shape in a process called "misfolding." The misfolded proteins accumulate together and…

Cardiac amyloidosis, traditionally considered a rare and dire disease, is receiving increasing attention as sophisticated diagnostics are identifying more patients…

Once used to diagnose myocardial infarction, technetium-99m pyrophosphate (Tc 99m PYP) imaging may be reborn as an alternative to biopsy for diagnosing cardiac…

Background: Technetium pyrophosphate (99mTc-PYP) imaging to diagnose transthyretin cardiac amyloidosis (ATTR-CA) has been increasingly utilized. The objective of…

Twitter Handle: Director, Cardiac Amyloidosis Program, Brigham and Women's Hospital and Harvard Medical School.

The official Twitter for the Brigham and Women's Hospital Amyloidosis Program.